CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
ZUG, Switzerland and BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 24th Annual Needham Virtual Healthcare Conference on Tue, April 8 at 12:45 p.m. ET.
A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the webcast will be archived on the Company's website for 14 days following the presentation.
About CRISPR Therapeutics
Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California. To learn more, visit www.crisprtx.com.
Investor Contact:+1-617-307-7503ir@crisprtx.com
Media Contact:+1-617-315-4493media@crisprtx.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
10 minutes ago
- New York Post
New Manhattan homes for menswear stores Charles Tyrwhitt, Tom Ford
London-based menswear store Charles Tyrwhitt is moving from 437 Madison Ave. to RFR Realty's 477 Madison, doubling its space in the process. Tyrwhitt signed for 3,800 square at the East 51st Street corner. The deal was handled for the landlord by MONA, a retail brokerage backed by RFR's Aby Rosen. Cushman & Wakefield acted for the tenant. Charles Tywhitt has a half-dozen Manhattan locations. Advertisement The building's offices are mostly leased. Recent signings include for Treville Capital and Fiera Capital. 477 Madison Ave. will be the new home menswear store Charles Tyrwhitt. One more Park Avenue office address has filled up. Advertisement Tom Ford Fashion signed a 10-year, 11,118 square-foot lease at SL Green's 500 Park Ave., bringing the landmarked, 201,000 square-foot building at East 59th Street to 100% leased. Tom Ford Fashion has signed a 10-year lease for 500 Park Ave., above. Brian Zak/NY Post Advertisement Other office tenants include The Georgetown Company, Vera Wang and Friedland Properties. Furniture store FRATO's flagship showroom is the retail tenant. Meanwhile, the former Hammacher Schlemmer headquarters building at 145 E. 57th St. can also boast 100% occupancy. Data Science Innovators took 5,067 square feet, landlord ABS Partners announced. Danish furniture maker Carl Hansen & Son replaced Hammacher Schlemmer on the retail floors.
Yahoo
28 minutes ago
- Yahoo
Developer seeks flexibility for design of affordable housing project
Jun. 8—ROCHESTER — A Santa Monica, California, developer is seeking support for deviating from Rochester development code standards to construct a 149-unit apartment complex along Fourth Street Southeast, just east of the Bear Creek Bridge. Lincoln Avenue Communities is proposing a 360-foot-long building, with a decreased rear setback along the river trail south of the site. The proposal exceeds length standards by 60 feet. "The length of this new building should not have any adverse impact on any abutting lots," Scott England, a principal with Minneapolis-based DJR Architecture, stated in a letter with Lincoln Avenue. "The building's length is broken up by multiple vertical architectural components that visually provide for pleasing visual breaks in the façade." Staff from the Rochester Community Development department are supporting the request, pointing to the ability to add downtown-adjacent parking with infill development across five lots, as well as efforts to provide an active use for the site that sits on a transit corridor. "The applicant has worked closely with city teammates to ensure compliance with the unified development code and district design standards," Rochester planner Elliot Mohler stated in a report to the Planning and Zoning Commission. "This includes street activation strategies such as benches, raised planters, additional plantings and bike parking." Lincoln Avenue Communities, which specializes in constructing and managing housing with rents below market rate, plans to lease apartments at rates considered affordable for households earning 60% of the area median income. "For a single parent with a few kids, this equates to $60,000 to $70,000 per year for income to qualify for housing, so it really is true workforce housing," Sarah Robbins, an associate with Lincoln Avenue Communities, told neighbors in April during a required informational meeting. Current state guidelines would cap potential rents at nearly $1,700 for a two-bedroom apartment under the tax credit program Lincoln Avenue seeks to utilize. The project is slated to feature 41 one-bedroom apartments, 77 two-bedroom units and 31 three-bedroom apartments, as well as one level of underground parking. While a site consolidation and a development plan for the project remain under review, the Planning and Zoning Commission will be asked to determine whether the construction variance will be allowed. Before making a decision, a public hearing on the issue will be held during the commission's meeting at 5 p.m. Wednesday in council chambers of the city-county Government Center. If development plans are approved, the apartment complex could be added to more than 150 Lincoln Avenue Communities properties throughout the nation. Company Vice President James Riley said the goal for the company's first Rochester project is to start construction in early 2026, if required development and financing approvals are obtained. Meetings scheduled to be held during the week of June 9 include: Rochester —City Council study session, 3:30 p.m. Monday in council chambers of the city-county Government Center, 151 Fourth St. SE. The meeting will livestream at and be available on Spectrum cable channel 180 or 188. —Police Policy Oversight Commission, 3:30 p.m. Tuesday in room 164B of the Development Services and Infrastructure Center, 4001 West River Parkway NW. —Sustainability and Resiliency Commission, 4:30 p.m. Wednesday in room 104 of City Hall, 201 Fourth St. SE. —Planning and Zoning Commission, 5 p.m. Wednesday in council chambers of the Government Center. —Citizens Advisory on Transit, 4:30 p.m. Thursday in room 104 of City Hall. Olmsted County —Housing and Redevelopment Authority, 4 p.m. Thursday in board chambers of the Government Center. Rochester Public Schools —School Board study session, 5:30 p.m. Tuesday in the boardroom of the Edison Building, 615 Seventh St. SW.
Business Insider
41 minutes ago
- Business Insider
The Week That Was, The Week Ahead: Macro & Markets, June 8, 2025
Everything to Know about Macro and Markets Stocks clocked in large weekly gains, returning to positive territory year-to-date. The Dow Jones Industrial Average (DJIA) rose by 1.17%, the S&P 500 (SPX) increased by 1.50%, and the tech-heavy Nasdaq-100 (NDX) gained 1.97% for the week. The S&P 500 finished more than 20% above April's low, reclaiming the 6,000 mark first reached in February, although it remained about 2% shy of its record high. Confident Investing Starts Here: Macro Steers the Markets The week began on a positive note, losing some steam in the second half. The weakness in PMI reports – with the manufacturing activity contracting for a third month in a row and services activity shrinking for the first time in 11 months – infused some gloom. However, Friday saw stocks find their footing again on solid job gains, which allayed fears about an imminent economic downturn. U.S. jobs growth stayed strong in May, climbing 139,000 with unemployment unchanged at 4.2%. Although the March and April reports were revised downward, May's report reassured investors, as it reflected a very gradual cooling of the labor market. Still, diving into the job report's details, a stronger-than-expected wage growth continues to put a floor under inflation. This supports the Federal Reserve's 'wait and see' stance, despite President Trump's demands for a cut. According to the CME FedWatch Tool, the chances of a June cut are nil, and July's rate decrease looks increasingly improbable. Prices in interest rate futures markets imply that investors expect two quarter-point rate cuts by year-end, with the first cut not expected until September. Wrapping Up the Season Despite tariff headwinds and macro volatility, S&P 500 companies delivered solid results last quarter. Index members reported 12.9% year-over-year earnings growth – the second straight double-digit increase. 78% of firms – above the five-year average – exceeded EPS estimates. However, the number of companies issuing negative EPS guidance (68) was also above the average. In Q1, the Healthcare sector reported the highest earnings growth, 43%, leaving the Magnificent Seven cohort's 27.7% increase in the dust. In fact, Mag 7's earnings growth rate was below the average (32.1%) of the previous three quarters. Still, three members of the Magnificent bunch – Alphabet (GOOGL), Amazon (AMZN), and Nvidia (NVDA) – are among the top five contributors to earnings growth for the S&P 500 for the first quarter. Interestingly, Bristol Myers Squibb (BMY) and Gilead Sciences (GILD) were the other top contributors. Stocks That Made the News ▣ Tesla (TSLA) lost nearly 15% over the week following the ugly social media spat between Elon Musk and President Donald Trump. The feud flared up over the impending budget bill, with Musk calling it 'disgusting', and followed by Trump's threat to take away billions of dollars in government subsidies and contracts awarded to Musk's businesses. Although shares rebounded on Friday as Musk and Trump moved to cool tensions, the spat cost Tesla over $150 billion loss in market cap. ▣ Broadcom (AVGO) fell on Friday, wiping out its weekly gain, after the chip giant only narrowly surpassed analyst revenue and expectations. In addition, its current quarter revenue guidance was also just above consensus. Solid, but not a blowout quarter and outlook, weighed on shares that recently hit all-time highs. Still, the company delivered on the AI narrative, reporting surging demand and upping AI networking revenue guidance. ▣ Microsoft (MSFT) continued its climb, hitting a fresh record on Friday as analysts raised price targets on acceleration in Azure and AI-related revenue growth. According to Goldman Sachs, Microsoft's cloud revenue could more than double by 2029. The tech leader's market cap has reached $3.5 trillion, surpassing that of Nvidia (NVDA) and making MSFT the largest company in the world. ▣ Lululemon (LULU) shares dove by 20% on Friday, capping large weekly losses, despite earnings beat. The apparel retailer cut guidance on macroeconomic uncertainty and the impact of tariffs that might force LULU to increase prices. ▣ DocuSign (DOCU) was another notable decliner, sinking nearly 19% post earnings. The company reported a strong financial performance, but a miss on billings raised investor fears about future growth. The Q1 2025 earnings season is practically over, but several notable earnings releases are still scheduled for the next few days. These include Casey's General (CASY), Oracle (ORCL), Chewy (CHWY), and Adobe (ADBE).
